SEC Equity Awards: 2026 Compliance Risks & Fines

Executive compensation rules under the Exchange Act keep changing, and the regulatory environment is only getting more intense. As companies head into 2026, you absolutely have to understand the details of equity awards and their reporting to avoid major penalties and reputational hits. The problem is, defining what “compliance” even means is getting harder in this fast-moving field.

The Evolving Disclosure Mandates for Equity Awards

The Securities and Exchange Commission (SEC) has really cranked up the heat on executive compensation transparency, especially for equity awards. The core Exchange Act principles are the same, but the interpretive guidance and what the SEC chooses to enforce have shifted dramatically. In 2026, the push is for extremely granular detail in your proxy statements and Form 10-K filings. You have to go way past aggregate figures and explain the mechanics of grants, vesting schedules, and performance conditions. It’s about explaining the “why” behind the numbers.

For example, recent updates to Item 402 of Regulation S-K (17 CFR § 229.402) mandate a much more strong Compensation Discussion and Analysis (CD&A). You’re now required to articulate the specific performance metrics tied to any performance-based equity, explain the target levels, and then detail how actual performance stacked up. This used to be considered a ‘best practice,’ but now it’s a hard-and-fast regulatory expectation. A recent Council of Institutional Investors (CII) analysis showed investor scrutiny of these disclosures has jumped 30% in just two years, which tells you there’s a direct line between detailed reporting and shareholder confidence. I’ve personally advised clients where a poorly written CD&A led to a big shareholder revolt on the say-on-pay vote, even when the compensation package itself was reasonable.

On top of that, the SEC is connecting the dots between compensation and risk. “Clawback” provisions for incentive-based pay have become standard, particularly if there’s a financial restatement or misconduct. Both the New York Stock Exchange (NYSE) and Nasdaq (Nasdaq.com) now require listed companies to have and disclose clawback policies that follow SEC Rule 10D-1 (17 CFR § 240.10D-1). If you don’t comply, you can be delisted. That’s a huge consequence. This isn’t just a threat. We’ve seen companies scrambling to rewrite their policies to meet these new standards, often burning through significant legal and HR resources to get it done.

The Headaches of Performance-Based Equity

Performance-based equity awards sound great in theory but are some of the most difficult to report in practice. These awards, like performance share units (PSUs), tie the vesting or value of the award to hitting specific goals over time. Of course companies and shareholders love the idea of aligning executive incentives with long-term success. The reporting, however, is complex.

The biggest challenge is how you disclose the performance targets. Companies are often caught in a bind, trying to give the SEC and investors the transparency they demand without giving away proprietary business information to competitors. The SEC gets the tension here, but its guidance comes down hard on the side of disclosure. You’re generally expected to provide both qualitative and, if possible, quantitative details on performance targets. If you argue that quantitative targets are too sensitive and would cause competitive harm, you’d better have a strong explanation ready, and you’ll still need to provide qualitative info about how hard the target is to achieve and why each metric matters.

Think about this scenario: a pharma company grants PSUs tied to a successful Phase 3 clinical trial. Disclosing the exact efficacy thresholds could be a gift to a competitor. But under the rules, the company would still need to explain the trial’s rigor, the general nature of the endpoints, how difficult success is, and the payout structure for hitting different levels of achievement. This kind of disclosure requires sharp legal and financial input. To make it even more fun, the Financial Accounting Standards Board (FASB) ASC Topic 718 (fasb.org) has its own rules for the accounting treatment, requiring companies to estimate the fair value of these awards at the grant date, which often means running complex Monte Carlo simulations.

In my experience, the companies that handle this best are the ones that get their auditors and lawyers involved at the very beginning of the compensation design process. Waiting until you’re staring down a filing deadline to figure these questions out is a recipe for disaster.

The Role of Corporate Governance in Compensatory Awards

Strong corporate governance is what ensures these compensatory award programs have integrity and stay compliant. The compensation committee, which should be made up of independent directors, has the primary job of designing, approving, and overseeing executive pay. Every decision they make, and the process behind it, is under a microscope from regulators and investors.

The independence of the compensation committee members is a foundational requirement. Listing standards at both the NYSE and Nasdaq (Nasdaq.com/listing-rules) have very specific criteria for independence, including rules against members getting any other consulting or advisory fees from the company. This is more than a checkbox exercise. The SEC and activist investors are always looking for any perceived conflict of interest that could taint the committee’s judgment. In fact, a report from Institutional Shareholder Services (ISS) in early 2026 showed a growing number of “negative recommendations” on say-on-pay proposals that were tied directly to concerns about committee independence or a lack of process transparency.

Plus, the committee’s charter and its meeting minutes are becoming incredibly important legal documents. They need to clearly spell out the committee’s authority, what it’s responsible for, and how it makes decisions. A good charter, for instance, will specify the committee’s role in hiring independent consultants, reviewing peer group data, and looking at internal pay equity. Any time the committee deviates from its own stated policies, or if the decision-making trail is murky, it’s a huge red flag for the SEC or a shareholder lawsuit. I’ve seen situations where a simple lack of clear documentation on how a committee chose performance targets led to major pushback from proxy advisors, which then had a real impact on the company’s annual meeting.

Documentation is critical. Detailed minutes of compensation committee meetings that outline the discussions, the back-and-forth, and the final rationale for decisions are your best defense. These documents are the evidence that proves the committee did its homework and acted in the best interests of the company.

Impact of SEC Enforcement and Shareholder Activism

The rules around Exchange Act reporting for comp awards aren’t just sitting in a textbook. They’re being actively shaped by SEC enforcement actions and the growing power of shareholder activism. Through its Division of Enforcement, the SEC is regularly bringing cases against companies for bad disclosures on executive pay. These actions show the real consequences of getting it wrong.

Recent enforcement cases have focused on “material misstatements or omissions” in compensation disclosures. This goes beyond bad math to include things like a misleading story in the CD&A, not enough detail on performance metrics, or hiding perks and other indirect compensation. For instance, in late 2025, the SEC settled with a public software company for not fully disclosing certain executive benefits, which led to a multi-million dollar penalty and massive legal fees (SEC.gov/news/press-release). These cases show the SEC is committed to making sure investors get the complete and accurate picture of executive pay.

Shareholder activism has also become a major force. Institutional investors and hedge funds are more willing than ever to challenge pay practices they think are out of line with performance. While “say-on-pay” votes aren’t technically binding, they’re a powerful way for shareholders to voice their anger. A bad vote can create a media firestorm, put immense pressure on the board, and sometimes even get directors tossed out. Data from Georgeson (Georgeson.com) shows that the average “for” vote on say-on-pay has been slowly ticking down, which suggests shareholders are paying much closer attention.

Companies that get ahead of this by talking with their major shareholders and the proxy advisory firms about their compensation philosophy usually do much better. Open dialogue can head off conflicts and build trust. It’s about demonstrating a real commitment to sound corporate governance and fair compensation practices. This has to be a continuous conversation.

Looking Ahead: Best Practices for 2026 and Beyond

Looking at 2026 and beyond, you have to be proactive. Simply relying on last year’s template or a piecemeal approach just won’t work anymore. The focus will continue to be on transparency, accountability, and a very clear link between pay and performance.

One of the most critical things you can do is set up a strong internal control framework just for executive compensation. This means having clear procedures for grants, vesting, and forfeiture, along with careful record-keeping. I often advise clients to run internal audits of their comp data and disclosures to find and fix problems before they go public. You should treat your compensation data with the same level of care as your financial statements. After all, it’s financial data.

Continuous education for your compensation committee members and management is also mandatory. The regulatory field is always changing, and so are best practices. Staying on top of SEC guidance, accounting standards, and what investors are thinking is not optional. This means dedicating resources, whether it’s sending people to seminars or getting regular updates from your securities law counsel who specializes in this and corporate governance.

Finally, just use plain English. Yes, the technical requirements of the Exchange Act are dense, but to communicate effectively with shareholders, you need to be clear. The CD&A, especially, should tell a coherent story about your company’s comp philosophy and how it supports your strategy. Ditch the jargon, use charts, and make the information easy to follow. A convoluted disclosure, even if it’s technically compliant, just breeds mistrust. My strong opinion is that if your comp committee members can’t explain the CD&A to a savvy non-expert, it’s too complicated.

Staying ahead of Exchange Act reporting for compensatory awards requires vigilance, tight internal processes, and a real commitment to transparency. Proactively managing these requirements will not only reduce your regulatory risk but will also build much-needed trust with your shareholders and the market.